4.66 USD
-0.01 (-0.21%)
4.62 USD
-0.04 (-0.86%)
Taking everything into account, CVAC scores 3 out of 10 in our fundamental rating. CVAC was compared to 525 industry peers in the Biotechnology industry. CVAC has an average financial health and profitability rating. CVAC is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year CVAC has reported negative net income.
- In the past year CVAC has reported a negative cash flow from operations.
- In the past 5 years CVAC reported 4 times negative net income.
- In multiple years CVAC reported negative operating cash flow during the last 5 years.
1.2 Ratios
- CVAC has a Return On Assets of 11.31%. This is amongst the best in the industry. CVAC outperforms 93.77% of its industry peers.
- CVAC has a better Return On Equity (14.79%) than 94.53% of its industry peers.
- CVAC has a Return On Invested Capital of 14.12%. This is amongst the best in the industry. CVAC outperforms 95.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.31% | ||
| ROE | 14.79% | ||
| ROIC | 14.12% |
ROA(3y)-13.91%
ROA(5y)-17.17%
ROE(3y)-24.58%
ROE(5y)-30.34%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 182.11%, CVAC belongs to the top of the industry, outperforming 98.49% of the companies in the same industry.
- With an excellent Operating Margin value of 212.01%, CVAC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- With an excellent Gross Margin value of 93.01%, CVAC belongs to the best of the industry, outperforming 93.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 212.01% | ||
| PM (TTM) | 182.11% | ||
| GM | 93.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- CVAC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- Compared to 1 year ago, CVAC has about the same amount of shares outstanding.
- CVAC has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for CVAC has been reduced compared to a year ago.
2.2 Solvency
- CVAC has an Altman-Z score of 4.23. This indicates that CVAC is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of CVAC (4.23) is better than 71.70% of its industry peers.
- A Debt/Equity ratio of 0.03 indicates that CVAC is not too dependend on debt financing.
- CVAC has a Debt to Equity ratio (0.03) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.23 |
ROIC/WACC1.96
WACC7.21%
2.3 Liquidity
- A Current Ratio of 3.70 indicates that CVAC has no problem at all paying its short term obligations.
- With a Current ratio value of 3.70, CVAC perfoms like the industry average, outperforming 44.91% of the companies in the same industry.
- CVAC has a Quick Ratio of 3.69. This indicates that CVAC is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of CVAC (3.69) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.7 | ||
| Quick Ratio | 3.69 |
3. Growth
3.1 Past
- CVAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -247.92%.
- The Revenue for CVAC has decreased by -86.98% in the past year. This is quite bad
- Measured over the past years, CVAC shows a very strong growth in Revenue. The Revenue has been growing by 98.42% on average per year.
EPS 1Y (TTM)-247.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.33%
Revenue 1Y (TTM)-86.98%
Revenue growth 3Y73.2%
Revenue growth 5Y98.42%
Sales Q2Q%-89.04%
3.2 Future
- CVAC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -22.50% yearly.
- Based on estimates for the next years, CVAC will show a very negative growth in Revenue. The Revenue will decrease by -11.14% on average per year.
EPS Next Y-163.99%
EPS Next 2Y-61.18%
EPS Next 3Y-28.72%
EPS Next 5Y-22.5%
Revenue Next Year-84.14%
Revenue Next 2Y-55.71%
Revenue Next 3Y-30.85%
Revenue Next 5Y-11.14%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CVAC. In the last year negative earnings were reported.
- Also next year CVAC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CVAC is valued cheaply inside the industry as 99.25% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.08 |
4.3 Compensation for Growth
- CVAC's earnings are expected to decrease with -28.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-61.18%
EPS Next 3Y-28.72%
5. Dividend
5.1 Amount
- No dividends for CVAC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CUREVAC NV / CVAC FAQ
Can you provide the ChartMill fundamental rating for CUREVAC NV?
ChartMill assigns a fundamental rating of 4 / 10 to CVAC.
Can you provide the valuation status for CUREVAC NV?
ChartMill assigns a valuation rating of 3 / 10 to CUREVAC NV (CVAC). This can be considered as Overvalued.
How profitable is CUREVAC NV (CVAC) stock?
CUREVAC NV (CVAC) has a profitability rating of 5 / 10.
What is the financial health of CUREVAC NV (CVAC) stock?
The financial health rating of CUREVAC NV (CVAC) is 5 / 10.
What is the expected EPS growth for CUREVAC NV (CVAC) stock?
The Earnings per Share (EPS) of CUREVAC NV (CVAC) is expected to decline by -163.99% in the next year.